The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19: An Observational Study

Chest. 2021 Jan;159(1):108-111. doi: 10.1016/j.chest.2020.06.082. Epub 2020 Jul 22.

Authors

Jasper Seth Yao¹, Joseph Alexander Paguio¹, Edward Christopher Dee², Hanna Clementine Tan³, Achintya Moulick¹, Carmelo Milazzo¹, Jerry Jurado¹, Nicolás Della Penna⁴, Leo Anthony Celi⁵

Affiliations

¹ Hoboken University Medical Center, Hoboken, NJ.
² Harvard Medical School, Boston, MA.
³ University of the Philippines College of Medicine, The Philippines.
⁴ Massachusetts Institute of Technology, Cambridge, MA.
⁵ Harvard Medical School, Boston, MA; Massachusetts Institute of Technology, Cambridge, MA. Electronic address: LCeli@mit.edu.

No abstract available

Publication types

Letter
Observational Study
Research Support, N.I.H., Extramural

MeSH terms

Aged
Aged, 80 and over
COVID-19 / mortality*
COVID-19 Drug Treatment*
Female
Hospitalization
Humans
Male
Middle Aged
Retrospective Studies
Survival Rate
Zinc / therapeutic use*

Substances

Zinc

Grants and funding

R01 EB017205/EB/NIBIB NIH HHS/United States